Relation of Pre-Event Use of Inhibitors of the Renin-Angiotensin System With Myocardial Infarct Size in Patients Presenting With a First ST-Segment Elevation Myocardial Infarction
Authors:
- Martin E. MatsumuraMMMartin E. Matsumura
- 1 September 2010
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 106 (5) , 646-649
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Cardioprotective effects of benazepril, an angiotensin-converting enzyme inhibitor, in an ischaemia-reperfusion model of myocardial infarction in ratsJournal of the Renin-Angiotensin-Aldosterone System, 2009
- Relation of Cardiac Troponin I Measurements at 24 and 48 Hours to Magnetic Resonance–Determined Infarct Size in Patients With ST-Elevation Myocardial InfarctionThe American Journal of Cardiology, 2009
- Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic eventsAmerican Heart Journal, 2009
- Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgeryJournal of Cardiovascular Medicine, 2008
- Utility of Cardiac Biomarkers in Predicting Infarct Size, Left Ventricular Function, and Clinical Outcome After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial InfarctionJACC: Cardiovascular Interventions, 2008
- Comparison of Troponin T to Creatine Kinase and to Radionuclide Cardiac Imaging Infarct Size in Patients With ST-Elevation Myocardial Infarction Undergoing Primary AngioplastyThe American Journal of Cardiology, 2008
- Partial Inhibition of Platelet Thromboxane A2 Synthesis by Aspirin Is Associated With Myonecrosis in Patients With ST-Segment Elevation Myocardial InfarctionThe American Journal of Cardiology, 2007
- Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialThe Lancet, 2004
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000